Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

107.18
BATS BZX Real-Time Price
As of 3:22pm ET
 +0.27 / +0.25%
Today’s Change
47.03
Today|||52-Week Range
111.49
+10.49%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 125.50, with a high estimate of 160.00 and a low estimate of 91.00. The median estimate represents a +17.09% increase from the last price of 107.18.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.68
Sales
$18.0M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -141.15%
 
 
 
 
 
 
Growthannually 37.33%
 
 
 
 
 
 

Sales

Growthquarterly -24.92%
 
 
 
 
 
 
Growthannually 35.39%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account